Zobrazeno 1 - 10
of 240
pro vyhledávání: '"Patrick, Dicker"'
Autor:
Fiona Cody, Orla Franklin, Nicola Mc Cay, Zara Molphy, Patrick Dicker, Fionnuala M. Breathnach
Publikováno v:
BMC Pregnancy and Childbirth, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Prenatal detection of critical congenital heart disease (CCHD) optimises perinatal decision-making and neonatal outcomes. The objective of this study was to determine the prenatal screening performance, care pathways and perinatal
Externí odkaz:
https://doaj.org/article/1ebfa74427ca41ab953cb5e3e0308007
Autor:
Elizabeth Loder, Jill Alison Hayden, David Torgerson, Tianjing Li, Wentao Li, Rui Wang, Ben W Mol, Lisa Bero, Jamie J Kirkham, Lisa Parker, Mike Clarke, Jo C Dumville, Calvin Heal, Lyle Gurrin, Andreas Lundh, Madelon van Wely, Toby Lasserson, Alison Avenell, Neil E O'Connell, Andrew Grey, Jack Wilkinson, George A Antoniou, Kylie Elizabeth Hunter, Patrick Dicker, Zarko Alfirevic, Ella Flemyng, Sarah Lensen, Emma Sydenham, Ginny Barbour, Emily Lam, Gideon Meyerowitz-Katz, James Heathers, Nicholas J L Brown, John Carlisle, Steph Grohmann, Barbara K Redman, Lene Seidler, Kyle A Sheldrick
Publikováno v:
BMJ Open, Vol 14, Iss 3 (2024)
Introduction Randomised controlled trials (RCTs) inform healthcare decisions. It is now apparent that some published RCTs contain false data and some appear to have been entirely fabricated. Systematic reviews are performed to identify and synthesise
Externí odkaz:
https://doaj.org/article/f39de58dcec344438e93f2289bdaea65
Autor:
Sarah M. Nicholson, Orla Smith, Susan Hatt, Zara Molphy, Patrick Dicker, Karen Flood, Fergal Malone
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background Induction of labour (IOL) at 39 weeks has been shown to decrease maternal and neonatal adverse outcomes. Given the growing demand for 39-week IOL, it is imperative that effective methods be assessed for induction in the outpatient
Externí odkaz:
https://doaj.org/article/5a5cff01da8d457fb7435ac569715f61
Autor:
Jill M. Mitchell, Patrick Dicker, Grace Madigan, Sarah Nicholson, Suzanne Smyth, Fionnuala M. Breathnach
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology: X, Vol 15, Iss , Pp 100148- (2022)
Objective: There exists uncertainty surrounding the most effective and efficient means of inducing labour, particularly in the setting of an unfavourable cervix. This study aims to determine the merit of repeating dinoprostone administration when a s
Externí odkaz:
https://doaj.org/article/9552e74aac2b4bedbd9005a0e3b55654
Autor:
Niamh C Murphy, Naomi Burke, Patrick Dicker, Fiona Cody, Etaoin Kent, Elizabeth C Tully, Fergal D Malone, Fionnuala M Breathnach
Publikováno v:
BMC Pregnancy and Childbirth, Vol 20, Iss 1, Pp 1-5 (2020)
Abstract Background The RECIPE study aims to validate a risk prediction model for intrapartum caesarean delivery which has been developed by our group. The Genesis study was a prospective observational study carried out by the Perinatal Ireland Resea
Externí odkaz:
https://doaj.org/article/b785bbcd2e514273b0c11359b7cf7a88
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Cigarette smoking negatively impacts on maternal and fetal health. Smoking cessation is one of the few interventions capable of improving pregnancy outcomes. Despite the risks, the most effective antenatal model of care for smoker
Externí odkaz:
https://doaj.org/article/9401f15c1641402393e7bccefa5535cf
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 281:36-40
Pregestational diabetes mellitus (PGDM) confers an increased risk of adverse maternal and neonatal outcomes [1,2]. Glycaemic control in the medium and long term is commonly evaluated by examining glycosylated haemoglobin (HbA1c) levels. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb95568d700a3ab762073539372acb2
https://doi.org/10.1016/j.ejogrb.2022.12.007
https://doi.org/10.1016/j.ejogrb.2022.12.007
Autor:
Catherine Finnegan, Patrick Dicker, Elena Fernandez, Elizabeth Tully, Mary Higgins, Sean Daly, Mairead O’ Riordan, Fidelma Dunne, Geraldine Gaffney, John Slevin, Vinete Ciprike, Fionnuala Breathnach
Publikováno v:
Contemporary Clinical Trials Communications, Vol 16, Iss , Pp - (2019)
Background: Preeclampsia, preterm birth and low birth weight represent key contributing factors to perinatal morbidity and mortality. Pregnancies complicated by type 1 and type 2 diabetes are at increased risk of these complications, which are purpor
Externí odkaz:
https://doaj.org/article/c8b6cfc3b5e14ada92cfbd0eff2bbe80
Autor:
Giuseppe Gullo, Alex J. Eustace, Alexandra Canonici, Denis M. Collins, Michael J. Kennedy, Liam Grogan, Oscar Breathhnach, John McCaffrey, Maccon Keane, Michael J. Martin, Rajnish Gupta, Gregory Leonard, Miriam O’Connor, Paula M. Calvert, Paul Donnellan, Janice Walshe, Enda McDermott, Kathleen Scott, Andres Hernando, Imelda Parker, David W. Murray, Alice C. O’Farrell, Ashwini Maratha, Patrick Dicker, Mairin Rafferty, Verena Murphy, Norma O’Donovan, William M. Gallagher, Bonnie Ky, Dimitrios Tryfonopoulos, Brian Moulton, Annette T. Byrne, John Crown
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: Combining bevacizumab and chemotherapy produced superior response rates compared with chemotherapy alone in metastatic breast cancer. As bevacizumab may cause hypertension (HTN) and increase the risk of cardiac failure, we performed a pil
Externí odkaz:
https://doaj.org/article/dd373e9d21d44deea251f3cc0cedb80b
Autor:
Annette T. Byrne, Jochen H.M. Prehn, Livio Trusolino, Claudio Isella, Andrea Bertotti, Diether Lambrechts, Enzo Medico, Rodrigo Dienstmann, Josep Tabernero, Guillem Argilés, Patrick Dicker, Matthias P.A. Ebert, Johannes Betge, Luise Halang, Bram Boeckx, Elodie Modave, Evy Vanderheyden, Manuela Salvucci, Eugenia R. Zanella, Francesco Sassi, Andreas U. Lindner, Niraj Khemka, Giorgia Migliardi, Alice C. O'Farrell, Adam Lafferty
Purpose:Regorafenib (REG) is approved for the treatment of metastatic colorectal cancer, but has modest survival benefit and associated toxicities. Robust predictive/early response biomarkers to aid patient stratification are outstanding. We have exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b03cb7f23937564cd04f0a66b41f08cc
https://doi.org/10.1158/1078-0432.c.6530519
https://doi.org/10.1158/1078-0432.c.6530519
